Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
114 studies found for:    FRONTOTEMPORAL DEMENTIA
Show Display Options
Rank Status Study
21 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
22 Recruiting Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Condition: Neimann-Pick Disease
Intervention: Drug: Vorinostat
23 Completed Longitudinal Study of Cognition With Niemann-Pick Disease, Type C
Condition: Niemann-Pick Disease, Type C
24 Completed
Has Results
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
Condition: Niemann-Pick Disease, Type C
Intervention: Drug: N-Acetyl Cysteine
25 Recruiting tDCS Intervention in Primary Progressive Aphasia
Conditions: Primary Progressive Aphasia;   MCI;   FTD
Interventions: Device: Active tDCS plus Speech-Language Therapy;   Device: Sham plus Speech-Language Therapy
26 Completed Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.
Conditions: Apathy;   Behavior;   Frontotemporal Dementia
Intervention: Behavioral: Evaluation of Apathy Close to Real Life Situation
27 Recruiting Genetics of Familial and Sporadic ALS
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
28 Recruiting Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C
Condition: Neimann-Pick Disease, Type C
29 Recruiting A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
Condition: Niemann-Pick Disease, Type C
30 Recruiting Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)
Conditions: Frontotemporal Dementia;   Huntington Disease;   Alzheimer Disease;   Semantic Dementia;   Dementia, Vascular
Intervention: Behavioral: prevalence of behavioural dysexecutive syndrome
31 Not yet recruiting Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia
Condition: Primary Progressive Aphasia
Intervention: Drug: F-18 AV 1451
32 Active, not recruiting Young Onset Dementia - the Difficult Diagnosis and the Stressful Life for the Whole Family
Conditions: Frontotemporal Dementia;   Alzheimer's Disease.
33 Enrolling by invitation Computational Tools for Early Diagnosis of Memory Disorders
Conditions: Alzheimer Disease;   Frontotemporal Dementia;   Dementia, Vascular;   Mild Cognitive Impairment
34 Withdrawn A Composite MR Neuroimaging Marker for Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Frontotemporal Dementia
35 Terminated Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
Condition: Dementia
Intervention: Drug: amantadine
36 Completed Treatment Study of Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration
37 Completed Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
Condition: Dementia
Intervention: Drug: memantine
38 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
39 Active, not recruiting Effects of Tolcapone on Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration
Interventions: Drug: Tolcapone;   Drug: Placebo
40 Terminated Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Conditions: Acid Sphingomyelinase Deficiency;   Niemann-Pick Disease
Intervention: Drug: rhASM

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years